Gainers
- Aerpio Pharmaceuticals ARPO shares increased by 20.68% to $1.4 during Monday's pre-market session. The market value of their outstanding shares is at $66.2 million.
- Milestone Pharmaceuticals MIST shares rose 10.99% to $6.16. The market value of their outstanding shares is at $183.8 million. The company's, Q1 earnings came out today.
- Onconova Therapeutics ONTX shares rose 10.74% to $0.58. The market value of their outstanding shares is at $137.8 million. As per the news, the Q1 earnings report came out today.
- Unity Biotechnology UBX shares increased by 9.52% to $4.6. The company's market cap stands at $252.3 million. As per the press release, Q1 earnings came out 4 days ago.
- Vyant Bio VYNT stock rose 9.3% to $3.64.
- Apellis Pharmaceuticals APLS stock increased by 8.45% to $48.0. The company's market cap stands at $3.8 billion.
Losers
- ADiTx Therapeutics ADTX shares declined by 13.05% to $2.0 during Monday's pre-market session. The market value of their outstanding shares is at $28.9 million.
- Assertio Holdings ASRT stock decreased by 8.6% to $0.45. The market value of their outstanding shares is at $78.2 million.
- Biomerica BMRA stock declined by 5.92% to $3.34. The company's market cap stands at $41.0 million.
- Nemaura Medical NMRD shares fell 4.98% to $8.78. The market value of their outstanding shares is at $201.3 million.
- Agile Therapeutics AGRX shares decreased by 4.97% to $1.53. The market value of their outstanding shares is at $135.0 million.
- Applied DNA Sciences APDN stock declined by 4.25% to $5.92. The company's market cap stands at $44.2 million. As per the press release, Q2 earnings came out 2 days ago.
AGRXAgile Therapeutics Inc COM PAR $0.0001
$1.49147.4%
APDNApplied DNA Sciences Inc
$0.1778-4.92%
APLSApellis Pharmaceuticals Inc
$33.210.21%
ASRTAssertio Holdings Inc
$0.90847.76%
BMRABiomerica Inc
$0.28637.63%
MISTMilestone Pharmaceuticals Inc
$1.783.79%
NMRDNemaura Medical Inc
$0.047623725.0%
UBXUnity Biotechnology Inc
$0.99442.53%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in